Icon Overview

  • Founded
  • 1990

Founded
  • Status
  • Public

  • Employees
  • 39,300

Employees
  • Stock Symbol
  • ICLR

Stock Symbol
  • Investments
  • 31

  • Share Price
  • $216.70

  • (As of Thursday Closing)

Icon General Information

Description

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Contact Information

Website
www.iconplc.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • South County Business Park
  • Leopardstown
  • Dublin 18
  • Ireland
+353 (01) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Icon Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$216.70 $217.27 $196.34 - $313.00 $17.7B 81.5M 503K $2.54

Icon Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 24,727,549 30,317,451 9,992,810 9,231,210
Revenue 6,524,392 5,480,826 2,797,288 2,805,839
EBITDA 780,795 604,902 458,013 495,339
Net Income 168,033 153,185 327,809 368,938
Total Assets 17,162,854 17,387,090 3,435,606 2,907,512
Total Debt 5,296,438 5,645,744 433,612 454,553
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Icon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Icon‘s full profile, request access.

Request a free trial

Icon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to
Drug Discovery
Dublin, Ireland
39,300 As of 2022
00000
000000000 00000

000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000 000000000
Ann Arbor, MI
00000 As of 0000
0000000 0000

000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
Chapel Hill, NC
000 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Icon Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Covance Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
000 Corporation Chapel Hill, NC 000 0000000000
000000000 00000000 Private Equity-Backed Nottingham, United Kingdom 000 00000000000
0000000 00000000 Corporate Backed or Acquired Kansas City, MO 000000&0
0000000 0000000000 Private Equity-Backed Newton, MA 00000 00000 000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Icon Executive Team (17)

Name Title Board Seat Contact Info
Steven Cutler Ph.D Board Member & Chief Executive Officer
Nuala Murphy Ph.D President, Development & Commercialisation
Brendan Brennan Chief Financial Officer, Finance
John Barry Senior Vice President & Chief Strategy Officer, SSD at ICON Global Strategic Solutions
Diarmaid Cunningham Board Member, Chief Administrative Officer, General Counsel, Executive Vice President, and Company Secretary
You’re viewing 5 of 17 executive team members. Get the full list »

Icon Board Members (15)

Name Representing Role Since
000000 000000 00 Icon Chairman 000 0000
00000 0000000 Icon Board Member 000 0000
000000 0000000 Icon Board Member 000 0000
0000 00000 Self Board Member 000 0000
0000 000000 Icon Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Icon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Icon Investments & Acquisitions (31)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000 00 01-Jul-2021 0000000000 0000 BPO/Outsource Services 000000 00
0000000 00000 22-Jan-2020 0000000000 000.00 Practice Management (Healthcare) 000000 00
00000000 0000 24-Sep-2019 0000000000 000.00 Clinics/Outpatient Services 000000 00
00000000 0000 23-May-2019 0000000000 000.00 Other Healthcare Services 000000 00
MolecularMD 25-Jan-2019 Merger/Acquisition 000.00 Biotechnology 000000 00
You’re viewing 5 of 31 investments and acquisitions. Get the full list »

Icon Subsidiaries (6)

Company Name Industry Location Founded
Symphony Clinical Research Clinics/Outpatient Services Vernon Hills, IL 2003
0000 0000000000000 Human Capital Services Amstelveen, Netherlands 0000
0000 0000000000 00 Other Healthcare Services Hinckley, OH 0000
0000000000 0000000 Clinics/Outpatient Services San Antonio, TX 0000
000 00000000 Laboratory Services (Healthcare) Winston-Salem, NC 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Icon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 09-Jul-2009 000000000000000000 000.00 Completed
  • 0000
To view Icon’s complete exits history, request access »